Back to News
Mergers & Acquisitions

Drinks With The Deal: Cleary Gottlieb's Jim Langston

|
Published: August 5th, 2021
Cleary Gottlieb's Jim Langston on the latest Drinks With The Deal podcast discusses how companies are responding to more vigorous antitrust enforcement.

“Antitrust is probably the highest-stakes issue in M&A today,” James Langston said on this week’s Drinks With The Deal podcast. “Across the globe, many regulators are taking a harder look at translations. Wherever you turn, it seems that big is now bad.”

Merging parties need to respond, said Langston, a partner at Cleary Gottlieb Steen & Hamilton LLP in New York. “Buyers and sellers need to have their eyes wide open. They need to have a strategy for getting the deal done, and they need to think about the regulatory process from a communications planning perspective, how they’re going to sell the deal not just to regulators but to government officials and other stakeholders. They need to be willing to advocate for the deal they believe in early and often and in a manner that reflects this new environment.”

Companies are responding to an environment in which “regulators have also been asking questions about deals they haven’t asked in the past,” Langston said, about issues that go beyond the consumer welfare standard that has been the focus of antitrust analysis for at least 40 years. “We’ll see if that’s just a shift in tone or a harbinger of something bigger.”

Here’s the podcast with James Langston:

More podcasts from The Deal are available on iTunesSpotify and on TheDeal.com.

More From Mergers & Acquisitions

Mergers & Acquisitions

Dow Considers Options for Infrastructure Assets

By Tom Terrarosa
|
Published: December 6th, 2023
The company is working with two bulge-bracket advisers to build a potential sale process around Gulf Coast infrastructure that sources said could amount to around $5 billion.
Mergers & Acquisitions

Resetting Expectations for IFF's Pharma Exit

By Tom Terrarosa
|
Published: December 5th, 2023
The chemicals conglomerate is said to need a deal for its pharma business, but the market may deliver it a disappointment on valuation.
Mergers & Acquisitions

Talking M&A: Competition Complexities

By The Deal Contributors
|
Published: November 20th, 2023
Following a number of crackdowns from global competition regulators, Baker McKenzie partners Duffy Lorenz and Creighton Macy share their experiences, insights and advice for clients looking to run a smooth deal process and minimize unexpected antitrust curveballs.